U.S. flag An official website of the United States government
  1. Home
  2. Drugs
  3. Drug Safety and Availability
  4. Postmarket Drug Safety Information for Patients and Providers
  5. Sprycel (dasatinib) Information
  1. Postmarket Drug Safety Information for Patients and Providers

Sprycel (dasatinib) Information

Sprycel (dasatinib) is a drug used to treat certain adult patients with Philadelphia chromosome-positive chronic myeloid leukemia (CML) or acute lymphoblastic leukemia (ALL).
 

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program using the contact information at the bottom of this page.

 

Related Information

Regulatory History and Labeling from Drugs@FDA